KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$25.51
+1.47%Year over year
Reported trailing growth
- Revenue
- +59.0%
- EBITDA
- -32.2%
- EBIT
- -26.7%
- EPS
- +33.5%
- Free cash flow
- -15.2%
- Operating cash flow
- -5.3%
Forward estimates
Based on analyst estimates
- Revenue
- +57.3%
- EBITDA
- +13.1%
- EPS
- +7.4%
Three-year CAGR
- Revenue
- +131.9%
- EBITDA
- -53.1%
- EBIT
- -26.7%
- Net income
- -15.6%
- EPS
- +52.6%
- Free cash flow
- -15.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Apr 1, 2026